November 6, 2025 - 09:25

In a recent discussion, Sam Altman emphasized the dual nature of artificial intelligence, highlighting both its potential benefits and inherent risks. He argued that as AI technology continues to advance, it is crucial for it to serve the needs of users effectively. Altman believes that the evolution of AI will necessitate a significant rethinking of how work is structured and how society functions as a whole.
He pointed out that while AI has the capability to enhance productivity and innovation, it also poses challenges that must be addressed responsibly. The integration of AI into various sectors could lead to shifts in job dynamics, requiring workers to adapt to new roles and skill sets. Altman stressed the importance of proactive measures to ensure that the advantages of AI are widely distributed, rather than concentrated in the hands of a few.
Ultimately, Altman calls for a balanced approach to AI development, one that prioritizes ethical considerations and the well-being of society as a whole.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...